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Antigenic differences between strains of influenza  viruses first were demon- 
st.rated  (1) shortly after the discovery of the agents. A large amount of study 
has been directed toward the extent  and the  significance  of such  differences 
(2-7).  The bull of the evidence indicates that strains obtained from a  single 
epidemic  do not  differ  strikingly  (5,  8-10)  but  that  strains  recovered from 
epidemics occurring in different years may show major antigenic  differences 
(11-13). Both the extent of the differences in antigenic composition and their 
bearing upon immunization against influenza have become increasingly  evident 
since  1947 when so called  influenza A prime strains  (14)  first were recovered 
and  vaccines prepared  with earlier strains  failed  to give  immunity  in man 
(iS). 
Not only do various strains of influenza  virus show antigenic differences  as 
early as they can be tested after recovery  from patients, but also a single 
strain may undergo antigenic variation during passage in laboratory hosts. 
Early work (16-18) indicated that antigenic  variation may occur when strains 
are adapted to a new host. Later studies (19-21) provided strong evidence  in 
support of this conclusion. There is now good reason to suspect that prolonged 
passage of influenza virus in any new species may lead to the development  of 
antigenic variation. Passage of two initially similar egg strains in mice has 
led to divergent changes in their antigenic patterns (19). 
Although the evidence for the occurrence  of antigenic variation with in- 
fluenza viruses is impressive, there is a ]ack of evidence  as to the mechanism 
by which such variants arise and become dominant. In  line with current 
concepts of mutation in microbial species, it might be assumed that naturally 
occurring variants of viruses are selected by chance on passage in unnatural 
hosts. This hypothesis has been offered  as an explanation for the variations 
observed on passage of influenza virus in the mouse lung (19). Although a 
similar hypothesis might be put forward for the  different strains recovered 
from man, an alternative requires consideration. Multiplication of influenza 
*  Fellow of the International Health Division of The Rockefeller Foundation on leave M 
absence from Istituto Superiore di Sanitli, Rome, Italy. 
441 442  PERSISTENT  ANTIGENIC  VARIATION  OF  INFLUENZA  A  VIRUS 
viruses  in  normal  laboratory animals  occurs  in  the  absence  of  any  induced 
immunity against the agents; circulating antibodies are not present.  In man, 
particularly in adults,  this is generally not  the  case and  as a  result of prior 
infections with the  agents  a  measure  of  induced  immunity  is  present;  cir- 
culating  antibodies are demonstrable in a  high proportion of instances  (22). 
Under these circumstances, if antigenic variants emerge during multiplication, 
the possibility arises that  those least neutralizable by the  antibodies present 
would be most likely to infect other susceptible cells. Thus,  in persons with 
different  infective  backgrounds  or  with  different  immunization  experiences 
who become infected with a  single strain, there could appear viral populations 
with  different  antigenic  patterns.  This  possibility has  been  considered pre- 
viously (10). 
The  hypothesis was  subjected to  experimental test  in  a  laboratory model 
in  the  following manner:  Different  strains  of influenza virus were  passed  in 
series in  the  chick embryo  in  the  presence  of immune  serum  against  other 
strains. The  quantity of serum  was  adjusted so that  the virus was partially 
but  not  completely neutralized  during  each  passage.  The  evidence  obtained 
in  this  study indicates that  antigenic variants emerge  regularly under  these 
conditions. The data indicate also that antigenic variation did not occur during 
limited serial passage in a  single host species in the absence of immune serum. 
In  addition,  evidence was  assembled which  suggests  that  the  antigenic pat- 
tern of the variant differs from that of the parent virus in a  manner predict- 
able in terms of the immune serum used and that the variant virus retains its 
altered antigenic pattern after further serial passage in the absence of immune 
serum. 
Materials and Methods 
Viruses.--Four strains of influenza A virus were used: one, PR8, has been through many 
mouse lung and chick embryo passages;  the others, SH, 965, and FM1, have not received 
mouse lung passages and have been through relatively few chick embryo passages: 5, 6, and 
10, respectively. 965 (10) was received from Dr. R. M. Taylor, International Health Division, 
The Rockefeller Foundation, and was recovered  from a patient ill in November, 1943. SH 
was recovered in this laboratory from a patient ill in March, 1948. PR8 (20) and FM1 (11) 
are well known strains which have been used by numerous  workers. Infected allantoic fluid 
was used as a source of virus; between experiments fluids were stored at --70°C. Virus dilu- 
tions were prepared in broth containing 10 per cent inactivated normal horse serum. In the 
experimental section the lines of a particular strain (e.g., FM1) are identified by subscripts 
as follows: original strain =  FMIo; control passage strain -- FMla; heterologous serum pas- 
sage strain =  FM1. (subscript  corresponding  to the heterologous strain, i.e., Sift). 
Virus Titrations.--Virus  infectivity titrations were done by the intra-allantoic technique 
described by Hirst (23). Hemagglutination titrations were done by the technique described 
by I-Iirst (24) using a final concentration of 0.5 per cent chicken RBC. 
Immune Serum.--Antiviral serum was prepared in rabbits as previously (25). Each was 
given 10 cc. of infected allantoic fluid intravenously and 1 week later received an additional 
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stored at 4°C. without preservative. Immune serum was prepared against each of the 4  vi- 
ruses before the experiments were begun. Additional immune serum was prepared after each 
of the viruses had been subjected to control serial passage in chick embryos as well as after 
serial passage in the presence of heterologous immune serum. In each instance 2 rabbits were 
immunized.  For hemagglutination-inhibition titrations and in  ovo  neutralization titrations, 
serum was inactivated at 56°C.  for 30 minutes. In the experimental section the various im- 
mune sera  against a  particular  strain  (e.g.,  FM1)  are  identified by subscripts as  follows: 
original antiserum  =  FMlo; control passage antiserum  --  FMla; antiserum prepared after 
passage  with  heterologous  serum  =  FM1,  (subscript  corresponding  to  the  heterologous 
strain, i.e., SH). 
Neutralizing  Antibody  Titrations,--In  ovo  neutralization titrations were carried out with 
twofold dilutions of inactivated serum and a  constant amount of virus by the technique de- 
scribed previously  (25).  A  10  -4 dilution of infected allantoic fluid, corresponding to  10  s to 
104 infective doses of virus, was employed. It has been shown that the experimental error of 
neutralizing antibody titrations carried out in this manner is no greater than that of hemag- 
glutination-inhibiting antibody titrations (25).  Pooled  serum  from  2  immune rabbits was 
used in each titration unless otherwise stated. Cross-neutralization titrations with 2 or more 
strains and corresponding antisera were, in so far as feasible, carried out simultaneously. 
Hemagglutination-lnhibitlng  Antibody  Titratlons.--These  were  carried  out  in  a  manner 
similar to that described by Hirst (24); the detailed procedure is given in a preceding paper 
(25). Final concentrations of 0.5 per cent chicken RBC and 8 hemagglutination units of viru-q 
were used. Pooled serum from 2 immune rabbits was used in each titration unless otherwise 
stated. Cross-hemagglutination-inhibition titrations with 2 or more  strains and  correspond- 
hag antisera were regularly carried out simultaneously. 
Antibody  Titer Rat/os.--The practice of Burnet and Lush (26), as modified by Hirst (5), 
of expressing the titration results obtained with a  particular serum in terms of the ratio of 
the heterologous titer divided by the homologous titer was employed to facilitate interpreta- 
tions of the results. The so called "avidity factor" employed by Hirst (5) was not used be- 
cause it was desired to make direct comparisons between results obtained by neutralization 
and hemagglutination-inhibition titrations, and there appears to be no justification for using 
an empirical correction factor with neutralization titrations. The method used for the analysis 
of the results, which is similar to that employed by Smith and Andrewes (4), makes such a 
correction factor unnecessary. The geometric mean of the ratio (rl),  found on dividing the 
heterologous titer obtained with virus 2 by the homologous titer obtained with virus  1, and 
the ratio (r2), found on dividing the heterologous titer obtained with virus 1  by the homolo- 
gous titer obtained with virus 2, is given by the function: r  =  ~  ×  %  The value r  gives 
in a  single figure the extent of the antigenic difference between 2 viruses when both agents 
and both antisera are used in a  cross-serological reaction. It is evident that when handled 
in this manner a  ratio greater than 1 (e.g.,  rl =  2) tends to cancel out with a corresponding 
ratio smaller than 1 (e.g.,  r2 =  I/,~) and when both are equal in extent yield a  value for r  -- 
1,  indicating no antigenic difference. Because the ratio r  is the geometric mean of the two 
ratios obtained with the heterologous viruses and the homologous sera, it yields a value which 
gives equal weight to differences found in either direction, i.e.,  serum 1 versus virus 2 and 
serum  2  versus  virus  1, and  makes  it  unnecessary  to  assume  that  antigenic  differences 
should  be reciprocal. In the various figures presented below, the ratio r is used in  the form 
1/r in order to simplify the data. As is evident, the homologous titer ratio is by definition 
1 in all instances. 
Serial Passages  of Virus.--A  10  -2 dilution of allantoic fluid infected with one strain was 
mixed with each of a series of twofold dilutions of inactivated immune serum against another 
strain. The mixtures were held at room temperature for 10 to  15 minutes and then 0.2 cc. AAA  PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A  VIRUS 
of each was injected into the allantoic sac; 3 embryos were used for each mixture. Allantoic 
fluid was harvested after 48 hours' incubation at 35°C. and tested by the hemagglutination 
technique.  Positive fluids from embryos which had received the highest concentration  of 
immune serum were used for passage. At each passage a 10-~  dilution of allantoic fluid, unless 
otherwise stated  in the experimental section, and a  series of twofold dilutions of immune 
serum were employed. After the desired number, 6 to 12, of serial passages in the presence of 
immune serum was completed, one additional allantoic passage without serum was made as 
routine. The only exception was with the SH-965 series. Infected fluid from the last passage 
was stored at -70°C. as a source of virus for antibody titrations and aliquots were used for 
immunization of rabbits as described above. In every instance a parallel control series of 
passages of equal number was carried out in which no immune serum was used. Infected 
TABLE I 
Cross-Hemagglutination-Inkibition Reactions witk 4 Strains of Influenza A  Virus 
Serum 
FM1 
SIt 
PR8 
965 
Virus* 
[  sH  I  ,R8  I 
Serum inhibition titer~ 
ego 
810 
160 
320 
512 
820 
64 
160 
160 
20 
2560 
320 
40 
40 
240 
1280 
Titer ratio§ 
FM1  1  I/1.2  1/4  1/16 
SH  2.5  1  1/16  1/8 
PR8  1/16  1/32  1  1/i0.7 
965  1/4  1/8  1/4  1 
* 8 units final of each virus. 
$ Each titer represents the geometric mean of 3 or more end-points. 
§ Titer ratio =  heterologous titer divided by homologous titer. 
allantoic fluid from the last passage of each control series also was stored at --70°C. as a 
source of virus for antibody titrations and aliquots also were used for immunization of rab- 
bits. 
EXPERIMENTAL 
Antigenic Relations between Original Strains.--The hypothesis which led to 
this study was as follows: Influenza viral populations are inhomogeneous as a 
result of the presence of antigenic variants which  arise  by chance  in  small 
numbers. Such variants can be selected by procedures  designed  to  separate 
them from the far larger number of typical viral particles. The objective of 
the investigation was to discover if the antigenic pattern of a  strain undergoes 
alteration on passage in the chick embryo in the presence of immune serum 
against a  different strain adjusted so as to cause only partial neutralization of 
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enza A viruses which were recovered in 1934  and 1943,  respectively; 2 others 
(FM1  and SH)  are so called influenza A  prime viruses which were recovered 
in  1947  and  1948,  respectively.  All  but  PR8  were  recovered first  in  chick 
embryos and had been carried through only 5 to 10 passages in this host. With 
the exception of PR8,  none of the strains had ever been passed in the mouse 
lung. 
The antigenic relations between the 4 strains were determined by serological 
tests.  Cross-hemagglutination-inhibition  reactions  were  carried  out  by  the 
methods  described  above and  the  results  are  shown  in  Table  I.  By  the  in 
vitro procedure there was no indication of a  difference between FM1  and SH 
TABLE II 
Cross-Neutralization Rec~tions with 4 Strains of Influenza A  Virus 
Serum 
FMI 
SH 
PR8 
965 
Virus* 
FM1  1  SH  I  PR8  I  965 
Serum neutralizing  titer~ 
320 
46 
5 
4 
95 
80 
2 
3 
40 
0 
2560 
40 
5 
2 
260 
160 
Titer ratio 
FM1  1  1/3.4  1/8  1/64 
SH  ~/1.7  1  1/80  1/40 
PR8  1/512  1/1280  1  1/9.8 
965  1/40  1/53  1/4  1 
* I0  -4 dilution of allanotic fluid. 
Serial twofold dilutions of inactivated  serum were employed. 
as  is  evident  from  the  various  titer  ratios.  By  means  of  the  ratio  r, 
(r = ~v/~),  as described above, the extent of the cross-relation between 
any 2 strains, as indicated by the 2 heterologous titer ratios, can be expressed 
in a  single figure. With FM1  and SH, r  --  1.4,  indicating no significant anti- 
genie  difference between  them.  A  definite  difference was found between  the 
antigenic patterns of PR8 and 965; r  =  1/6.5.  Even more marked differences 
were revealed when FM1  was compared with 965; r  --  1/8.  Equally definite 
differences emerged when SH was related to 965; r  --  1/8. It is important to 
reiterate that FM1,  SH, and 965 had been passed only in the chick embryo. 
Thus,  it appears that  there are clear differences between strains of influenza 
A virus which have not been subjected to laboratory passage in a mammalian 
host. 
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the  methods  described above  and  the  results are shown  in Table  II. Much 
more  striking  antigenic  differences  between  the  strains  were  revealed  by 
neutralization  than  by  hemagglutination-inhibition.  This  becomes  evident 
TABLE III 
Cross-Hemagglutination-Inhibition Reactions with Original and Control Embryo Passage Strains 
Serum 
FMI o 
SH  o 
"  C~ 
PR8  o 
"  C§ 
965  o 
"  C§ 
FM1 o 
(¢  C 
SH  o 
c~  C 
PR8  o 
965  o 
((  C 
Virus* 
FM1  SH  PR8  965 
J  :'1  c:  o  o  ct  cl  o  [  cl 
Serum inhibition titer 
1280 
6a,  O 
910 
2560 
512 
SS0 
320 
810 
250 
9r~0 
320 
1820 
9560 
640 
640 
240 
19~0 
640 
810 
160 
160 
1620 
9040 
Titer r~tio 
1 
2.5  2.8 
4 
1/1.2 
1 
112 
1.3 
1/1.3 
1 
1  1/IA 
1 
1/2 
1/8.2 
1/10.7 
I 
1/16 
1/16 
1.2 
1 
* 8 units final each virus, o =  original; c =  control passage. 
After 12 embryo passages. 
§  "  6  .... 
II Each titer represents the geometric mean of 2 or more end-points. 
when the various titer ratios are compared. The difference between FM1 and 
SH is indicated by r  =  1/2.4; between PR8 and 965  by r  --  1/6.3; between 
FM1  and 965  by r  ---  1/50.6;  and between SH and 965  by r  =  1/46.  These 
results provide  additional confirmation for  the view  (10-13)  that  strains  of 
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passages  in  the  chick  embryo  may reveal  striking  differences in  antigenic 
patterns. 
A~igotic  Relations  between Original  and Control Passage  Strains.--Before 
attempting to interpret  changes which resulted from chick embryo passage 
in the presence of heterologous immune serum, it was essential to discover if 
any demonstrable  antigenic  alterations  occurred  on  control passage  of  the 
strains in the chick embryo in the absence of serum. Both FM1 and SH were 
subjected to 12 serial passages in the chick embryo; PR8 and 965 were carried 
TABLE  IV 
Cross-Neutralization  Reactions ~vitl~ Original and Control Embryo Passage Strains 
Serum 
PR8 o 
c~  ¢~ 
965  o 
PR8 o 
c~  c 
965  o 
~  c 
Virus" 
PR8  ]  965 
o  I  c$  o  I  c:~ 
Serum neutrslizlng fiter 
2560 
40 
2560 
820 
20 
80 
260 
160 
T|ter ratio 
1/4  1/8 
1/8 
119.8 
320 
20 
16o 
640 
118 
1/8 
* 10  -4 dilution each virus. 
:~ After 6 embryo passages. 
through 6 serial passages in this species.  In these control experiments immune 
serum  was  not  employed. The procedure  used  was  identical with  that  de- 
scribed above and immune sera were prepared with the original strains as well 
as with each of the strains after completion of the control passages. 
Antigenic relations between the original and control passage  strains were 
determined by serological tests, The results of cross-hemagglutination-inhibi- 
tion reactions are shown in Table III. In no instance did the original (sub- 
script o) and the control passage (subscript c) hnes show evidence of significant 
antigenic differences. This is most clearly evident when the titer ratios ob- 
tained  with each  of  the  strains  and  their  corresponding  immune sera  are 
compared.  Even  when antisera  against heterologous strains,  i.e.,  SH versus 
FM1, or 965 versus PR8, were employed, no evidence was found that antigenic 448  PERSISTENT  ANTIGENIC  VARIATION  OF IN~LIYENZA  A  VIRUS 
differences had arisen as a result of 6 to 12 serial passages in the chick embryo 
in the absence of immune serum. 
The result of cross-neutralization reactions with the original (o) and control 
passage (c) lines derived from PR8 and 965 are shown in Table IV. As with the 
in  vitro reactions,  there  was  close  correspondence between  the  titer  ratios 
found with  each of the  original  and control lines.  This provides additional 
evidence in support of the conclusion that no change in the antigenic pattern 
was occasioned by limited passage in the chick embryo itself. On the basis of 
this evidence, it seemed justifiable to consider that significant alterations in 
antigenic pattern which appeared after passage in the presence of heterologous 
immune serum were attributable to the antiviral serum. 
Reduction in Neutralizability  of Strains on Passage in the Presence of tteter- 
ologous Immune Serum.--Eight  series of serial passages  were carried out in 
which dilutions of heterologous immune sera were mixed with a  strain prior 
to each passage. Each of the 4 strains was employed in one or more of the series; 
the experimental conditions are described above. A condensed summary of the 
results is shown in Table V. In the first 6 series a constant amount of virus, 
i.e. 10  -3, was employed with twofold dilutions of immune serum; in the last 2 
series,  as little as a  10  -7  dilution of virus was used in order to obtain some 
neutralization  of  the  heterologous strain.  Increasing  amounts  of  the  same 
immune serum were required to neutralize a constant amount of each virus as 
the serial passages were continued in the first 6 series. In the case of the last 
2 series with SH and 965, complete neutralization was not obtained even when 
high concentrations of serum, i.e.  1 : 2, and very small amounts of virus, 10-  7, 
were employed. The results show that there was in the first 6 series a progressive 
decrease in the neutralizability of the virus by heterologous immune serum 
and  provide  an  indication  that  the  antigenic  patterns  of  the  strains  were 
undergoing alteration as the passages continued. Direct tests of this postulate 
are recorded below. 
Antigenic  Variation with SH and FM1 on Passage with Heterotogous Immune 
Serum.--Two separate and complete experiments, in each of which  12 serial 
passages were carried out, were undertaken with SH and FM1.  In the first 
experiment one pair  of heterologous immune  sera  was  used;  in  the  second 
another pair of similar immune sera was employed. The procedures used and 
the controls employed are described above. 
The results  of cross-neutralization reactions with  SH,  FM1,  and variants 
derived from each on passage in the presence of heterologous immune serum 
are shown in Table VI. From the titer ratios it is evident that SHe, the strain 
derived from SH on passage with anti-FNI1  serum, differed from the parent 
virus  (SH).  Evidence  for  an  antigenic  difference was  obtained  after  both 
independent  experiments.  Similarly,  the  titer  ratios  reveal  that  FBtII,,  the 
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differences  in antigenic pattern from the parent virus  (FM1).  The  antigenic 
differences  between the 2 parent strains and the variants derived from them, 
TABLE V 
Decrease in Virus Neutralization on Serial Passage in Presence of Heterologous Immune Serum 
FM1 
SH 
FM1 
SH 
PR8 
965 
SH 
965 
Viras 
Dil. 
10-~ 
10-7 
cc 
Serum* 
SH  (a) 
FM1 (a) 
SH (b) 
FM1 (b) 
965 
PR8 
965 
10--~ 
10-7 
SH 
Passages in 
presence  of 
serum 
No. 
0 
6 
12 
0 
6 
12 
0 
6 
12 
0 
6 
12 
0 
6 
12 
Dilution of serum 
required to neutralize virus 
20 
10 
<5 
40 
40 
10 
20 
5 
<5 
80 
40 
40 
40 
10 
<2 
80 
5 
<2 
<2 
<2 
<2 
0 
6 
12 
<2 
<2 
<2 
Change 
Iotd 
>4 
>4 
>20 
>40 
* a and b indicate sera from different pairs of rabbits. 
as  determined  by in  ovo  neutralization  reactions,  are  depicted  graphically  in 
Fig.  1. 
The ratios (r)  represent the geometric means of the 2 heterologous titer ratios (rl and r~) 
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means of the equation r  =  ~/~ X  r2, and gives in a  single figure the extent of the dissimi- 
larity in the antigenic patterns of 2 strains. It is noteworthy that, in each ease, the ratio r 
is dependent upon a minimum of 4 antibody titrations. Under the conditions of these experi- 
ments, values of 1/r of 2 or more may be considered significant. The larger the value of r, 
the greater is the antigenic dissimilarity. It can be shown that, on a percentage basis, a value 
TABLE  VI 
Cross-Neutralizatlon Reactions with SH, FM1, and  Variants  Derived from Each  on Passags 
with tteterologous Immune Serum 
Experiment 
Virus* 
sH. 
SHf 
FM1. 
FM1, 
SHo 
SHt 
FMlo 
FM1, 
SHo 
SHt 
FMlo 
FM1, 
SHo 
SHf 
FMIo 
FM1, 
SIlo  I  SHf  I  FMlo  [  Fro, 
Serum neutralizing titer 
160 
80 
80 
5 
20 
160 
40 
5 
40 
160 
3¢t0 
40 
0 
$ 
20 
160 
Titer ratio 
1 
1/2 
1/4 
1/32 
1/8 
1 
1/8 
1/32 
114 
1 
1 
1/4 
1/150 
1/32 
1/16 
1 
Serum neutralizing titer 
II  160  20  40  0 
80  40  160  10 
80  40  820  20 
5  2  40  8O 
Titer ratio 
1  1/8  1/4  1/150 
2  1  4  1/4 
1/4  1/8  1  i/i6 
1/16  1/40  1/2  1 
* Subscript o  =  original; c  =  after control passage; f  --- after passage with FNI1 serum; 
s  =  after passage with SH serum. 
of 2 for 1/r is equivalent to an antigenic cross-relationship of 50 per cent; 4  --  25 per cent; 
8  -=  12.5 per cent; 16 =  6.2 per cent; 32 --  3.1 per cent; 64 =  1.6 per cent; 128  -- 0.8 per 
cent; etc. 
The variant  derived from  SH  (SHf)  and  the variant  derived from FM1 
(FM1.) were different  in antigenic  pattern from the parent viruses which had 
been subjected to parallel  control passages of equal duration.  Closely similar 
results  regarding  the  antigenic  variations  induced  by this  procedure  were I.  ARCHETTI  AND  F. L.  HORSI~ALL, JR,  451 
evident  both  in  Experiments  I  and  II,  indicating  that  the  alterations  were 
reproducible under the experhnental conditions employed. 
Bt-I  5Hf  FI'I1  :FI"II~ 
Exp.  III  I  II  I  I[  I  II 
16 
16 
32  .t 
!I"  '" 
~2 
64 
I! 
Fzo. 1. Extent of in ovo cross-neutralization  reactions with SI-I, FMI, and variants de- 
rived from them on serial passage i~ ovo in presence of heterologous immune serum. Experi- 
ments I and II were identical but independent.  The ratio r, shown as the reciprocal, is the 
geometric  mean  of the 2 heterologous  titer ratios  and represents  the degree of antigenic 
dis.dmilarity between any 2 strains. The larger the value of l/r, the greater is the difference 
in the antigenic patterns of 2 strains. Homologous ratios are by definition equal to 1. Serum 
titers and titer ratios are shown in Table VI. 
Cross-hemagglutination-inhibifion  reactions  between  SH,  FMI,  and  the 
variants  derived from them on passage with heterologons immune serum  axe 
shown  in  Table  VII.  From  the  titer  ratios  obtained  it  is  obvious  that  the 
differences  between  SHf  and  SI-L revealed  by  cross-neutralization  reactions 
in ovo were not apparent by  cross-hemagglutination-inhibition  reactions after 
either Experiment I  or II. The antigenic differences between  FMIs and FMIo, 452  PERSISTENT ANTIGENIC VARIATION  OF Iik~LUENZA  A  VIRUS 
however, were of an extent closely similar to those found by in vivo reactions. 
The differences in the antigenic patterns between the parent strains and their 
variants, as shown by hemagglutination-inhibition reactions, are shown graph- 
ically in Fig. 2. The ratio r employed is identical with that used in Fig. 1. It is 
TABLE VII 
Cross.ttemagglutination-Inhibition  Re~tions with Stt, FM  I, and Variants Derived  from Eack 
Experiment 
on Passage ~ith Heterologous Immune Serum 
Serum* 
Virus* 
SHe  I  SHf  ]  FMIo  I  FM1, 
Serum inhibition  titer 
I  SI-L  39.0  160  640  40 
SHf  640  9"40  1280  320 
FMlo  320  160  1280  160 
FM1,  320  60  320  1280 
Titer ratio 
SIlo  1  1/2  2  1/8 
SH~  2.6  1  5.3  1/1.3 
FMlo  1/4  1/8  1  1/8 
FM1,  1/4  1/21.3  1/4  1 
Serum/nhibitlon titer 
II  SHo  640  320  2560  80 
SHf  640  820  1280  640 
FMlo  320  320  2§60  320 
FM  I B  320  80  320  1580 
Titer ratio 
SHo  1  1/2  4  1/8 
SH~  2  1  4  2 
FMlo  1/8  1/8  1  1/8 
FM1,  1/4  1/16  1/4  1 
* Symbols are identical with those used in Table VI. 
clear  that  the  in vitro  reactions,  although revealing somewhat less marked 
differences than the in ~ivo reactions, showed that the variant FMI, derived 
from FM1 was markedly different from the parent virus which had been sub- 
jected to parallel control serial passage. Of importance is the additional evidence 
that the results obtained in the two separate experiments were closely similar 
indicating a high degree of reproducibility. 
The data shown in both Figs. 1 and 2 demonstrate that the variant FM1. 
differed from SH to a much greater degree than the parent FM1. Because the I. ARCHETTI  AND  F. L. HORS]?ALL,  JR.  453 
variant was obtained on passage with anti-SH, such an alteration in antigenic 
pattern was to be expected in terms of the postulate stated above. It appears 
clear that prolonged passage of either SH or FM1 in the presence of antiserum 
against the other resulted in each of the two experiments in the emergence of 
variant viral strains possessing antigenic patterns different from those of the 
parent  strains.  Because  closely similar  differences were found after passage 
with either of the 2 pairs of immune  sera employed, it seems  that  the anti- 
genic pattern of the variant virus is reproducible to a surprising degree. 
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FIO. 2. Extent of cross-hemagglutinafion-inhibifion  reactions with SH, FM1, and variants 
derived from them on serial passage in ovo in presence of heterologous  immune serum. Serum 
fiters and fiter ratios are shown in Table VII. 
Antigfnie Variaion with PR8 and 965 on Passage with tteterologous  Immune 
Serum.--Two  successive  experiments,  consisting  of  6  serial  passages  each, 
were carried out with  PR8 and 965.  In the first experiment each virus was 
passed  in  the  presence of immune  serum  against  the  other.  Following  this 
experiment  additional  passages  were  carried  out  without  serum  employing 
the strains obtained from the first experiment. The objective was to discover 
if antigenic differences emerging in the first experiment would persist during 
a  second  passage  series  in  the  absence  of  an  environment  experimentally 
arranged to select variants  of different antigenic pattern.  The experimental 
procedure was identical with that described above and included, as in experi- 
ments with the other viruses, parallel series of control passages without serum. 
Results of cross-neutralization reactions with PR8 and 965, as well as the 454  PERSISTENT  ANTIGENIC  VARIATION  O]~ INFLUENZA  A  VIRUS 
variants derived from them in the two successive experiments,  are shown in 
Table VIII. From the titer ratios it is evident that there was some antigenic 
difference between PR8o and PRS0, the variant obtained from PR8 by passage 
in the presence of anti-965  serum; the difference was shown more clearly by 
TABLE VIII 
Cross-Neutralization Reactions with PRS, 965, and  Variants Derived from Each on Passage 
wlth Heterologous Immune Serum 
Experiment 
I 
With serum 
II 
Additional passages 
without serum 
Serum* 
PR8o 
PRS, 
9650 
965p 
PR8o 
PR8, 
965o 
965p 
PR8o 
PR8, 
9650 
965p 
PR8o 
PR89 
9650 
965p 
Vires* 
PRSo  I  PRS,  I  96~.  I  9~p 
Serum neutralizing titer 
2860 
1280 
20 
160 
1 
4 
1/8 
1/2 
9560 
1280 
20 
150 
! 
8 
1/8 
1 
1280  320 
320  2 
5  160 
10  150 
Titer ratio 
1/2  1/8 
1  1/160 
1/32  1 
1/32  1/2 
Serum neutralizing titer 
1280  320 
160  2 
5  160 
10  160 
Titer ratio 
1/2  1/8 
1  1/80 
1/32  1 
1/16  1 
150 
0 
40 
890 
1/16 
1/320 
1/4 
1 
160 
2 
40 
160 
1/16 
1/80 
1/4 
1 
* Subscripto =  original; c = after control  passage; 9 --- after passagewith965; p =  after 
passage with PR8 serum. 
the reactions with heterologous immune sera, i.e.,  9650 and 965p. Clear differ- 
ences in antigenic pattern were revealed between 965o and 965p, the variant 
derived from 965 on passage in the presence of anti-PR8 serum. The antigenic 
differences  appeared  during  serial  passages  carried  out  with  heterologous 
immune  serum  in  the  first  experiment;  of  more  importance,  they persisted 
during serial passages in the second experiment when no immune serum was 
employed. The results after conversion to the ratio r by means of the equation 
given above are shown in Fig. 3. The extent of the differences  between strains I. ARCIIETTI  AND  i~. L. HORSI~ALL~  JR.  455 
is  indicated  by the  length  of the  blocks.  The fact  that  variants  arose  and 
persisted for at least 6  passages in the absence of serum is evident from the 
results  obtained  both  with  homologous immune sera and  with heterologous 
immune sera. 
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F[o. 3.  Extent of in ¢vo cross-neutralization reactions with PR8, 965, and variants de- 
rived from them on serial passage in ova in presence of heterologous immune serum. Experi- 
ment I, with immune serum; Experiment II, addifio'~al passages without serum. Serum  fiters 
and  titer ratios are shown in Table VIII. 
The  results  of cross-hemagglutination-inhibition  reactions  with  PR8,  965, 
and variants  derived  from them  are  shown  in Table IX.  With  this pair of 
viruses,  in contrast  to SH and  FM1,  the extent  of the  antigenic  differences 
appears  to  be  more  evident  from the  hemagglutination-inhibition  reactions 
in vitro than from the neutralization  reactions in vivo. The finding with PR8 
and 965, as well as with SH and FM1, that in vitro and in vivo cross-serologlcal 456  PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A  VIRUS 
reactions were not strictly comparable, either qualitatively or quantitatively, 
is consistent with  the evidence obtained earlier  (25)  indicating  that  hemag- 
glutination-inhibiting and neutralizing antibodies against influenza viruses are 
not identical. That the variant strain PR89 was different from the parent, PRS, 
TABLE IX 
Cross-Hemagglutination-Inhibition Reactions with P R8, 965, and Variants Derived from Each 
on Passage with Heterologous Immune Serum 
Experiment 
I 
With serum 
II 
Additional passages 
without serum 
Serum* 
PRSo 
PR89 
9650 
965p 
PR8o 
PR89 
9650 
965p 
PR8o 
PR89 
9650 
965p 
PR8o 
PR89 
9650 
9650 
Virus* 
PR8a  ]  PR8,  I  965o  ]  96,5p 
Serum inhibition tlter 
9fi60 
2560 
320 
320 
1 
2 
1/8 
1/8 
9560 
5120 
320 
1280 
1 
1 
118 
1/4 
320  320 
1280  80 
80  2560 
160  640 
Titer ratio 
1/8  ,  1/8 
1  ,  1116 
1/32  i  1 
1/16  i  114 
Serum inhibition titer 
320  320 
5190  80 
80  9.560 
160  1280 
Titer ratio 
1/8  118 
1  1/54 
1132  1 
1/32  1/4 
40 
40 
160 
i  2560 
1164 
i  1132 
i  1/16 
i  1 
40 
160 
160 
5120 
1/64 
1/32 
1/16 
1 
* Symbols are identical with those used in Table VIII. 
and that the variant 965p was different from the parent, 965, seems evident. 
Again, as in the neutralization reactions, the differences are clearly seen with 
heterologous sera,  e.g.,  PR8o and  PR89  versus  serum 965o. These results are 
presented graphically in Fig. 4. The evidence indicates that the variant strains 
obtained in  the first experiment were  antigenically dissimilar  to  the parent 
strains  and reacted less  well with heterologous immune  sera used  to  select 
them than did the parent viruses. Such a  change in antigenic pattern was to 
be expected in terms of the original hypothesis. I.  ARCHETTI  AND  F.  L.  HORSFALL,  JR.  457 
The changes induced in PR8 indicate that antigenic variants can be obtained 
even from a  very old laboratory strain  (20)  which has been carried through 
hundreds of passages  in various host species.  The persistence of the  altered 
antigenic patterns of the variants through additional passages in the absence 
of immune  serum  is  clearly indicated  by the  close similarity in  the  results 
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FIo. 4.  Extent of cross-hemagglutiuation-inhibition reactions with PR8,  965, and variants 
derived from them on serial passage in ova  in  the presence of  heterologous immune serum. 
Serum titers and titer ratios are shown in Table IX. 
obtained in the first and succeeding experiments. The evidence suggests that, 
once a  new antigenic pattern has emerged, it may remain as a  transmissible 
character in the absence of a selective environment. 
Antigenic Patterns of SH and 965 after Passage with Heterologous Immune 
Serum.--Experiments  similar to those described above also were carried out 
with SH and 965. This pair of viruses was chosen because they were so markedly 
different  both  in  cross-neutralization  and  cross-hemagglutination-inhibition 
reactions  as  is  evident  from  the  results presented  in  Tables  I  and  II.  The 
objective was to discover if antigenic variants could be obtained from widely 458  PERSISTENT ANTIGENIC VARIATION O]~ INFLUENZA A  VIEUS 
different strains by the procedure employed with  strains  of  closer  relation. 
Twelve serial passages  with  each virus  were carried out in  the presence of 
immune serum against the other. The experimental conditions and the control 
passages were identical with those employed in the preceding experiments with 
the exception that  after the first few passages very small inocula, i.e.  10  -z, 
were mixed with undiluted immune serum in an effort to obtain partial neutrali- 
zation. 
The  results  of  cross-neutralization  and  cross-hemagglutination-inhibition 
reactions with SH, 965, and the substrains obtained from them are shown in 
TABLE X 
Cross-Serological Reactions with SH, 965, and Substrains Obtained on Passag¢  with Heterologous 
Immune Serum 
Serum* 
Virus* 
SH~  I  S~,  ]  965.  9S. 
Serum neutralizing titer 
SI-I~  4O  80  0  0 
965°  2  0  160  160 
Titer ratio 
SHo  1  2  1/40  1/40 
965~  1/80  1/160  1  1 
Serum inhibition tlter 
SI~  160  160  4O  20 
965~  160  40  1280  640 
"liter ratio 
SHo  1  I  1/4  1/8 
965°  1/8  1/32  1  1/2 
* Symbols identical with those used in other tables. 
Table X. In this experiment immune sera were not prepared against either of 
the strains  after they had been passed in the presence of heterologous anti- 
sera. This was thought to be unnecessary when the titer ratios indicated that 
there was  but little evidence of an antigenic difference between either sub- 
strain and the corresponding parent strains. Results after computation of the 
ratio r  by the  function given above are presented graphically in  Fig.  5.  It 
is clear that there was no significant difference between SH and SHg, the sub- 
strain derived from SH after passage in the presence of anti-965 serum. There 
was, however, some suggestion of a difference in antigenic pattern between 965 
and 965a, the substrain derived from 965 on passage in the presence of anti-SH I.  ARCHETTI  AND  F.  L.  HORSFALL~  yR.  459 
serum. Because this difference was evident only  in hemagglutlnation-lnhibition 
reactions and immune sera against the substrains were not available for con- 
firmatory cross-serological reactions, it is doubtful that any significant evidence 
of antigenic variation was obtained with SH and 965. With strains as widely 
different  as  SH and  965,  which  fail  to  show significant  evidence of cross- 
neutralization  in  ovo, it  would  not  be  anticipated  that  antigenic  variants 
should emerge under the experimental conditions employed. 
Neut~alization  Hema  9g:lutination. 
Inhibition 
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FIO. 5. Extent of in ow and in vitro cross-serological  reactions with SH, 95S, and sub- 
strains obtained from them on serial  passage in o~o in presence of heterologous immune 
serum. Serum titers  and titer  ratios  are shown in Table X. 
DISCUSSION 
Influenza  viruses  appear  capable  of variation  with  respect  to  a  number 
of properties and show evidence of variation with surprising  frequency under a 
wide  range  of  experimental  conditions.  Evidence  of  variation  relative  to 
pathogenicity for various  species of laboratory animals,  particularly  ferrets 
(27),  mice  (28),  hamsters  (29),  and  chick embryos (18) has  been obtained. 
Variation relative to the capacity to agglutinate erythrocytes of chickens  and 
guinea pigs (30) also occurs and is especially marked with strains of influenza 
A virus (31). Variation affecting the rate of elution from erythrocytes has been 
demonstrated; such variants are obtained after treatment with physical (ultra- 
violet irradiation)  or chemical  (lanthanum  acetate)  agents  (32).  With a  few 
strains strikingly abnormal variants pathogenic for the central nervous system 
have been obtained (33, 34). Among the array of properties which show varia- 
tion with these infectious agents, that which is most arresting is variation in 460  PERSISTENT  ANTIGENIC  VARIATION OF  INFLUENZA  A  VIRUS 
antigenic pattern.  Marked  alterations in  the  antigenic structure  of viruses 
raise problems of wide theoretical interest which also have obvious practical 
implications relative to identification, classification and immunization. 
Variation in the antigenic constitution of influenza viruses may occur when 
a  change in the host species  is made and prolonged serial  passage in a  new 
host is carried out. There are indications that this may happen when chick 
embryos (18), embryo tissue cultures (16, 17), or mice (19, 21) are substituted 
for other host species.  Strong evidence for antigenic variation  on  so  called 
adaptation  to  the  mouse  lung  has  been  assembled--sufficient  to  make  it 
doubtful that the antigenic pattern of a mouse-adapted strain is a valid indi- 
cation of the pattern of the original strain (19).  As has been emphasized by 
Hirst (19) the comparison of the antigenic patterns of different mouse-adapted 
strains or of such strains with egg strains may lead to serious errors in assessing 
antigenic differences. 
That variation in antigenic pattern also occurs on natural transmission of 
influenza viruses from man to man seems highly probable. This view is sup- 
ported by earlier work (10) as well as by the evidence presented in this paper 
that strains of influenza A virus obtained in different years and maintained 
only in chick embryos for but a few passages show wide antigenic differences. 
That the small number of passages employed did not occasion the observed 
differences seems probable from the finding that, in numerous series,  as many 
as 12 additional control passages in the embryo caused no demonstrable altera- 
tion in the antigenic pattern of any of 3 egg strains.  This view is supported 
also by the now extensive evidence indicating that most egg strains obtained 
from a single epidemic are closely related (5, 9, 10) as well as by the fact that 
repeated recoveries in eggs of virus from a  single patient yield strains which 
appear indistinguishable. 
If the appearance of a variant with an antigenic pattern different from that 
of the original viral strain is the result of spontaneous variation analogous to 
the phenomenon of mutation in microbial species,  it would be expected that 
the variant should replace the original strain whenever the host preferentially 
favored the multiplication of the variant. Moreover, it would be predicted that 
the antigenic pattern of the dominant variant should remain as a  fixed and 
transmissible character until another variant  arose which could replace  the 
first. One means of favoring the selection of a  variant of different antigenic 
pattern is to arrange conditions so that when a large number of viral particles 
are inoculated a large proportion are neutralized by antibody but those variant 
particles which react least with the antibody remain capable of multiplication. 
That such a procedure is effective and leads to the emergence of strains with 
antigenic patterns different from those of the parent strains appears evident 
from the results of this study. 
The evidence indicates that strains which are related,  to  the extent that I. ARCHETTI  AND  F. L. HORSI?ALL,  JR.  461 
they show appreciable cross-neutralization, yield antigenic variants on passage 
in the presence of heterologons immune serum. That such variants retain their 
new antigenic patterns on passage in the absence of a  selective environment 
appears evident. How long the new character may persist remains to be de- 
termined. The apparent predictability of the antigenic pattern of the variant 
is not to be taken as an indication of a fimited capacity of the virus to undergo 
variation but in all probability is simply a  reflection of the specificity of the 
immune sera used to produce a selective environment. Evidence of predictable 
variation has  been  obtained  previously with  influenza viruses  treated  with 
either ultraviolet irradiation or lanthanum acetate (32) as well as with mumps 
virus  on  inhibition  of  multiplication  with  the  capsular  polysaccharide  of 
Friedl~inder bacillus (35). 
With influenza viruses a fixed non-varying antigenic constitution probably 
does  not  occur.  An  antigenic  variant  was  obtained  from  PRS,  which  has 
undergone  hundreds  of passages  in  numerous  species  since  its  recovery in 
1934, with as much ease as from any of the other strains which had been through 
only a few passages in a single host. It seems probable that by means of the 
procedure employed in this study antigenic variants could be obtained from 
any  strain  and  that  with  different immune  sera  further variants  could  be 
selected from those which arise initially. Whether such a stepwise selection of 
variants  would make possible the development of an A prime strain from a 
typical A strain or vice versa remains to be determined. 
The fact that  the  antigenic dissimilarities between the  original strains  as 
well  as  between  these  strains  and  variants  derived  from  them  were  both 
qualitatively and quantitatively different in  cross-neutralization experiments 
as  compared  to cross-hemagglutination-inhibition experiments provides con- 
firmatory evidence for the  concept  (25)  that  antibodies  measurable  by the 
in vivo technique are not identical with those measurable by the in vitro pro- 
cedure. 
SUMMARY 
Antigenic  variants  of influenza A  virus  strains  emerge  on  serial  passage 
in  ovo in the presence of immune serum against different but related strains. 
An old laboratory strain  (PRS)  which had been through hundreds of animal 
passages was as readily modified by this procedure as recently recovered strains. 
Such variants apparently can be obtained at will and show antigenic patterns 
which are reproducible and appear to be predictable in terms of the immune 
serum  used  for  their  selection.  Variant  strains  retain  their  new  antigenic 
patterns  on serial passage  in  ovo  in  the absence of immune serum.  Limited 
serial passage in ovo of strains in the absence of immune serum did not result 
in  the  emergence of antigenic variants.  Similarly,  serial passages  of strains 
in ovo in the presence of immune serum against widely different strains, which 462  PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A  VIRUS 
failed to show significant cross-neutralization,  did not lead to the appearance 
of antigenic variants. 
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